MLIV Research
MLIV Research, funded by the ML4 Foundation, supports collaborative scientific projects to advance understanding and therapy development for mucolipidosis type IV.
Funder: ML4 Foundation
Due Dates: Rolling (Contact foundation to discuss proposals)
Funding Amounts: No specified limits; awards historically support multi-year research (e.g., 3-year studies) and major laboratory/clinical projects.
Summary: Funds collaborative research to advance understanding and develop therapies for mucolipidosis type IV (MLIV).
Key Information: Proposal-driven; no open calls—contact the foundation to initiate discussion.
Description
The MLIV Research program, supported by the ML4 Foundation, aims to accelerate scientific discovery and therapeutic development for mucolipidosis type IV (MLIV), a rare lysosomal storage disorder. The foundation prioritizes collaborative research efforts, particularly in gene therapy, disease mechanisms, natural history studies, biomarker discovery, and clinical trials. Projects are selected in close consultation with a scientific advisory board and leading international researchers, with an emphasis on innovative and translational science that can move the field toward effective treatments and, ultimately, a cure.
